Wegovy / Wegovy HD (semaglutide) Wegovy injection is used with a reduced-calorie diet and increased physical activity to: reduce the risk of major cardiovascular events (death, heart attack, or stroke) in adults with known heart disease and either obesity or overweight
EASO Congress Proceedings
Data or Concepts to Include: Obesity and type 2 diabetes have clinical trial evidence
Patients should be advised to contact their GP if they experience persistent nausea, vomiting, abdominal pain, or inability to tolerate oral intake after restarting Wegovy
Whether this wave leaves a legacy of empowerment or erosion of trust will depend not on algorithms, but on governance
Sudden, widespread muscle injury due to trauma, toxins, venoms, or drugs suggests that these agents cause direct muscle membrane injury